首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.
【24h】

Antithrombin-mediated inhibition of factor VIIa-tissue factor complex by the synthetic pentasaccharide representing the heparin binding site to antithrombin.

机译:代表肝素与抗凝血酶结合位点的合成五糖对凝血酶VIIa-组织因子复合物的抗凝血酶介导抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

We examined the effect of the synthetic pentasaccharide representing the minimal binding site of heparin to antithrombin on the antithrombin-mediated inactivation of factor VIIa bound to tissue factor. This effect was compared to the effect of unfractionated heparin. Using purified recombinant human coagulation factors and either a clotting or an amidolytic assay for the determination of the residual activity of factor VIIa, we showed that the pentasaccharide was an efficient antithrombin-dependent inhibitor of the coagulant activity of tissue factor-factor VIIa complex. In our experimental conditions, assuming a mean MW of 14,000 for heparin, the molar pseudo-first order rate constants for ATIII-mediated FVIIa inhibition by ATIII-binding heparin and by the synthetic pentasaccharide were found to be similar with respective values of 104,000 +/- 10,500 min-1 and 112,000 +/- 12,000 min-1 (mean +/- s.e.m., n = 3).
机译:我们检查了代表肝素与抗凝血酶的最小结合位点的合成五糖对抗凝血酶介导的与组织因子结合的因子VIIa失活的影响。将该效果与普通肝素的效果进行了比较。使用纯化的重组人凝血因子并通过凝血或酰胺水解测定来测定因子VIIa的残留活性,我们表明五糖是一种有效的抗凝血酶依赖性抑制剂,可抑制组织因子-VIIa复合物的凝血活性。在我们的实验条件下,假设肝素的平均分子量为14,000,发现ATIII结合的肝素和合成的五糖对ATIII介导的FVIIa抑制的摩尔假一级速率常数相似,分别为104,000 + / -10,500 min-1和112,000 +/- 12,000 min-1(平均+/- sem,n = 3)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号